These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3451667)

  • 1. [Effects of 2,2'-[(4,8-bis(diethylamino)-pyrimido[5,4-d]pyrimidine-2,6-diyl) di-(2-methoxyethyl)imino]diethanol (RA 642) on experimental scald shock].
    Yin M; Liao XL; Tan SJ
    Zhongguo Yao Li Xue Bao; 1987 Nov; 8(6):533-6. PubMed ID: 3451667
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RA 642, a pyrimido-pyrimidine-derivative with vasodilating and hypertensive potency.
    Kadatz R; Kobinger W; Walland A
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):97-103. PubMed ID: 940597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H; Smith BA; Lefer AM
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of RA 642 on cerebrocortical perfusion in acute hemorrhagic shock in rats.
    Hergenröder S; Reichl R
    Prog Clin Biol Res; 1989; 308():1091-5. PubMed ID: 2780688
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of sympathetic cardiovascular centres by RA 642, a new pyrimido-pyrimidine derivative.
    Kobinger W; Walland A; Kadatz R
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):105-11. PubMed ID: 940592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the severity of burn shock in irradiated animals under the influence of blood serum alpha- and beta-globulins].
    Nesterenko VS; Lifshits RI; Piskarev AV; Efimenko GP
    Patol Fiziol Eksp Ter; 1990; (4):15-6. PubMed ID: 1706827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a new derivative of pyrido-(2,3-D)-pyrimidine (LK 42/82) on blood pressure in normo- and hypertensive animals].
    Kozłowska T; Olejnik A; Chodera A; Sołoducho J; Kuczyński L
    Acta Pol Pharm; 1987; 44(6):572-6. PubMed ID: 3454113
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antishock effectiveness of anabol in irradiated animals].
    Nesterenko VS; Chureeva LN; Piskarev AV; Iakovlev VA; Matveeva IA
    Patol Fiziol Eksp Ter; 1987; (6):53-5. PubMed ID: 3444673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the pharmacodynamic properties of promedol, droperidol and dimedrol in burn shock and combined radiation-thermal injury].
    Il'iuchenok TIu; Matveeva IA; Budagov RO
    Farmakol Toksikol; 1987; 50(1):71-4. PubMed ID: 3556555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and cardiotonic activity of pyrazolylpyrimidines].
    Sedereviciute V; Garaliene V; Vainilavicius P; Hetzheim A
    Pharmazie; 1998 Apr; 53(4):233-7. PubMed ID: 9583084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the proteinase inhibitor (aprotinin) on the course of experimental burn shock].
    Rybák M; Petz R; Jańecek J; Petáková M
    Cas Lek Cesk; 1976 Sep; 115(35):1067-71. PubMed ID: 1086136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic and protective properties of dimebon in burns].
    Shadurskiĭ KS; Matveeva IA; Il'iuchenok TIu
    Farmakol Toksikol; 1983; 46(5):90-2. PubMed ID: 6628665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of 6-methyl-7-diethylamino-s-triazolo-(1,5-a) pyrimidine (Trapymin, Rocornal), a new compound with vasodilative effects].
    Füller H; Hauschild F; Modersohn D; Thomas E
    Pharmazie; 1971 Sep; 26(9):554-62. PubMed ID: 5137075
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
    Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
    Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and positive inotropic activity of several 5-aminopyrido[2,3-d]pyrimidines. Part 5: Compounds with positive inotropic activity.
    Heber D; Ravens U; Schulze T
    Pharmazie; 1993 Jul; 48(7):509-13. PubMed ID: 8415847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of fluorocarbon emulsion on the cardiovascular system].
    Chen WZ; Li HQ; Shen YT; Dong YL; Ding XC
    Yao Xue Xue Bao; 1986 Feb; 21(2):86-91. PubMed ID: 3751596
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-shock effects of corticosteroids observed in traumatic shock rats (author's transl)].
    Suemori I
    Masui; 1977 Oct; 26(10):1124-31. PubMed ID: 926285
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of potential beneficial actions of prostaglandins in traumatic shock.
    Lefer AM; Araki H
    Prog Clin Biol Res; 1983; 111():199-210. PubMed ID: 6346328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.